Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
20111.1k citationsSamuel A. Wells, Bruce G. Robinson et al.Journal of Clinical Oncologyprofile →
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011767 citationsÉric Baudin, David Lebwohl et al.profile →
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
2012616 citationsÉric Baudin, Eric P. Krenning et al.Neuroendocrinologyprofile →
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
2009487 citationsJames C. Yao, Catherine Lombard‐Bohas et al.Journal of Clinical Oncologyprofile →
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
2016403 citationsRocio García‐Carbonero, Halfdan Sørbye et al.Neuroendocrinologyprofile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
2017303 citationsAnders Sundin, Rudolf Arnold et al.Neuroendocrinologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Éric Baudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Baudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Baudin more than expected).
This network shows the impact of papers produced by Éric Baudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Baudin. The network helps show where Éric Baudin may publish in the future.
Co-authorship network of co-authors of Éric Baudin
This figure shows the co-authorship network connecting the top 25 collaborators of Éric Baudin.
A scholar is included among the top collaborators of Éric Baudin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Éric Baudin. Éric Baudin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sundin, Anders, Rudolf Arnold, Éric Baudin, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. Neuroendocrinology. 105(3). 212–244.303 indexed citations breakdown →
9.
García‐Carbonero, Rocio, Halfdan Sørbye, Éric Baudin, et al.. (2016). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology. 103(2). 186–194.403 indexed citations breakdown →
10.
Baudin, Éric, et al.. (2014). Bureau Veritas Sloshing Model Tests & CFD Calculations for ISOPE Sloshing Benchmark. The Twenty-fourth International Ocean and Polar Engineering Conference.2 indexed citations
11.
Baudin, Éric, et al.. (2013). Increasing ULCS Structural Response Knowledge Through 3DFEM and a Comprehensive Full-Scale Measurement System. The Twenty-third International Offshore and Polar Engineering Conference.2 indexed citations
Wells, Samuel A., Bruce G. Robinson, Robert F. Gagel, et al.. (2011). Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial. Journal of Clinical Oncology. 30(2). 134–141.1082 indexed citations breakdown →
15.
Fillon, B., et al.. (2011). Statistical Post-Processing of Long-Duration Sloshing Test. The Twenty-first International Offshore and Polar Engineering Conference.9 indexed citations
16.
Faßnacht, Martin, Massimo Terzolo, Bruno Allolio, et al.. (2011). Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study. 26.2 indexed citations
17.
Yao, James C., Catherine Lombard‐Bohas, Éric Baudin, et al.. (2009). Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial. Journal of Clinical Oncology. 28(1). 69–76.487 indexed citations breakdown →
Bachelot, Anne, J. Leclère, Éric Baudin, & Martin Schlumberger. (2002). Démarche diagnostique devant un nodule thyroïdien. 4(1). 48–52.
20.
Tartour, Éric, M Schlumberger, Thierry Dorval, Éric Baudin, & Wolf H. Fridman. (1995). [Endocrine involvement in immunotherapy].. PubMed. 56(2). 143–8.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.